Yvonne Ou, MD, is a board certified ophthalmologist who specializes in glaucoma, including medical, laser and surgical therapies; cataract evaluation and treatment including combined cataract and glaucoma surgery; glaucoma filtering and implant surgery; and newer procedures in the MIGS category. Her research interests are in the area of glaucoma neurodegeneration, and she has dedicated her efforts towards the goal of developing new diagnostics and therapies. Clinical research interests include the relationship between glaucoma and other neurodegenerative diseases. Her laboratory is currently studying which types of retinal ganglion cells are more susceptible or resistant to injury from glaucoma, as well as whether specific visual pathways exhibit plasticity and the ability to recover after injury. As a clinician-scientist, Dr. Ou’s overall goal is to elucidate diagnostic and therapeutic targets earlier in the course of the disease and translate these findings to help improve the vision and quality of life of glaucoma patients.
Dr. Ou received her B.A. in biochemistry magna cum laude from Harvard University, and her M.D. magna cum laude from Harvard Medical School. She completed ophthalmology residency at the Jules Stein Eye Institute, UCLA. Dr. Ou then completed both clinical and research glaucoma fellowships at Duke University. She received the Young Investigator Award from the Alcon Research Institute in 2012 and the Dr. Douglas H. Johnson Award for Glaucoma Research from the BrightFocus Foundation in 2016.
Yvonne Ou, MD
Associate Professor in Residence
Department of Ophthalmology
University of California, San Francisco